The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
To mark International HPV Awareness Day on March 4th 2022, the International Papillomavirus Society (IPVS) has warmly welcomed two major advances in the elimination of cervical and anal cancers
Covaxin is not approved in the USA for any age group
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
The first wave of shipments includes several countries, such as Germany, France and Austria
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
Apexxnar is the first pneumococcal conjugate vaccine to help protect adults ages 18 years and older against 20 serotypes responsible for the majority of invasive disease and pneumococcal pneumonia
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Subscribe To Our Newsletter & Stay Updated
